Search Results - Saillard, Juliette, MSc

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

    Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 random... by Raffi, François, Prof, Babiker, Abdel G, Prof, Richert, Laura, PhD, Molina, Jean-Michel, Prof, George, Elizabeth C, MSc, Antinori, Andrea, MD, Arribas, Jose R, MD, Grarup, Jesper, DVM, Hudson, Fleur, BA, Schwimmer, Christine, PhD, Saillard, Juliette, MSc, Wallet, Cédrick, MSc, Jansson, Per O, RN, Allavena, Clotilde, MD, Van Leeuwen, Remko, PhD, Delfraissy, Jean-François, Prof, Vella, Stefano, MD, Chêne, Geneviève, Prof, Pozniak, Anton, MD

    Published in Lancet neurology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1 : a substudy of the NEAT001/ANRS143 randomised trial

    Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with... by Bernardino, Jose I, Mocroft, Amanda, Mallon, Patrick W, Wallet, Cedrick, Gerstoft, Jan, Russell, Charlotte, Reiss, Peter, Katlama, Christine, De Wit, Stephane, Richert, Laura, Babiker, Abdel G., Buño, Antonio, Castagna, Antonella, Girard, Pierre-Marie, Chene, Genevieve, Raffi, Francois, Arribas, Jose R, Odermarsky, Michal

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial

    Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial by Chéret, Antoine, Dr, Nembot, Georges, MD, Mélard, Adeline, MSc, Lascoux, Caroline, MD, Slama, Laurence, MD, Miailhes, Patrick, MD, Yeni, Patrick, Prof, Abel, Sylvie, MD, Avettand-Fenoel, Véronique, PharmD, Venet, Alain, MD, Chaix, Marie-Laure, MD, Molina, Jean-Michel, Prof, Katlama, Christine, Prof, Goujard, Cécile, Prof, Tamalet, Catherine, MD, Raffi, François, Prof, Lafeuillade, Alain, MD, Reynes, Jacques, Prof, Ravaux, Isabelle, MD, Hoën, Bruno, Prof, Delfraissy, Jean-François, Prof, Meyer, Laurence, Prof, Rouzioux, Christine, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: